Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021005684
Abstract: Key Points G-CSF is an effective long-term therapy for SCN with a wide range of effective doses requiring individualized dose titration. Eleven percent of patients with CN developed MDS/AML; patients with autoimmune/idiopathic neutropenia did not… read more here.
Keywords: outcomes patients; severe chronic; chronic neutropenia; patients severe ... See more keywords